“…Clinical studies have demonstrated encouraging results and improvement of myocardial function after transplantation of different types of stem cells (2,3,58,59). Nevertheless, the advancement of regenerative medicine has faced several obstacles, most of which relate to the fact that highly potent cell sources for repair, engraftment, and survival after transplantation are not definitively identified (60)(61)(62) (16,33). Similarly, preconditioning of stem cells before transplantation, by genetic modification or by priming with cytokines, growth factors, small molecules, or other pharmacological approaches, has shown significant effects on survival and engraftment (17,18,50,63,64).…”